Design and evaluation of novel N-substituent diphenylamine derivatives as tubulin colchicine binding site inhibitors
- 16 November 2024
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 115, 130031
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitorsBioorganic & Medicinal Chemistry Letters, 2024
- Tubulin degradation: Principles, agents, and applicationsBioorganic Chemistry, 2023
- Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitorsBioorganic Chemistry, 2019
- Synthesis of Combretastatin‐A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin PolymerizationChemMedChem, 2019
- Current advances of tubulin inhibitors as dual acting small molecules for cancer therapyMedicinal Research Reviews, 2019
- Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding siteEuropean Journal of Medicinal Chemistry, 2018
- Interspecies differences in metabolism of deoxypodophyllotoxin in hepatic microsomes from human, monkey, rat, mouse and dogDrug Metabolism and Pharmacokinetics, 2016
- Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effectsThe International Journal of Biochemistry & Cell Biology, 2013
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding SitePharmaceutical Research, 2012
- Novel Tubulin Polymerization Inhibitors Overcome Multidrug Resistance and Reduce Melanoma Lung MetastasisPharmaceutical Research, 2012